During the past decade, Royal Brompton Hospital; Respiratory Department conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Royal Brompton Hospital; Respiratory Department" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Asthma" (2 trials) and "Lung Diseases, Interstitial" (1 trials). Many other conditions were trialed in "Royal Brompton Hospital; Respiratory Department" in a lesser frequency.

Most popular intervention types in "Royal Brompton Hospital; Respiratory Department" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Lebrikizumab" (3 trials), "Pirfenidone" (3 trials), "PRM-151 (Zinpentraxin Alfa)" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Brompton Hospital; Respiratory Department" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Royal Brompton Hospital; Respiratory Department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Royal Brompton Hospital; Respiratory Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Brompton Hospital; Respiratory Department, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".